Physiologically based pharmacokinetic (PBPK) modeling in children
- PMID: 22669290
- DOI: 10.1038/clpt.2012.64
Physiologically based pharmacokinetic (PBPK) modeling in children
Abstract
This review summarizes the present status of physiologically based pharmacokinetic (PBPK) modeling and simulation (M&S) and its application in support of pediatric drug research. We address the reasons that PBPK is suited to the current needs of pediatric drug development and pharmacotherapy in light of the evolution in pediatric PBPK methodologies and approaches, which were originally developed for the purpose of toxicologic evaluation. Also discussed is the current degree of confidence in using PBPK to support pediatric drug development and registration and the key factors essential for robust results and broader adoption of pediatric PBPK M&S.
Comment in
-
Physiologically based pharmacokinetic modeling at the extremes of age.Clin Pharmacol Ther. 2013 Feb;93(2):148. doi: 10.1038/clpt.2012.176. Epub 2012 Nov 21. Clin Pharmacol Ther. 2013. PMID: 23169431 No abstract available.
-
Response to "Physiologically based pharmacokinetic modeling at the extremes of age".Clin Pharmacol Ther. 2013 Feb;93(2):149. doi: 10.1038/clpt.2012.200. Epub 2012 Nov 28. Clin Pharmacol Ther. 2013. PMID: 23187875 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical